|
|
Volumn 347, Issue , 2013, Pages
|
|
New oral hypoglycaemics fail to show cardiovascular benefits.
a
a
BMJ
*
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADAMANTANE;
ALOGLIPTIN;
ANTIDIABETIC AGENT;
DIPEPTIDE;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
DRUG DERIVATIVE;
PIPERIDINE DERIVATIVE;
SAXAGLIPTIN;
URACIL;
CARDIOVASCULAR DISEASE;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT FAILURE;
ADAMANTANE;
CARDIOVASCULAR DISEASES;
DIPEPTIDES;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
HUMANS;
HYPOGLYCEMIC AGENTS;
PIPERIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT FAILURE;
URACIL;
|
|
EID: 84886683084
PISSN: None
EISSN: 17561833
Source Type: None
DOI: 10.1136/bmj.f5458 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
